Medicine and Dentistry

1. Patient 100%
2. Inpatient 95%
3. Consensus 63%
4. Complication 63%
5. Implantable Automatic Defibrillator 45%
6. Combination Therapy 44%
7. Heart Ventricle Arrhythmia 40%
8. Subcutaneous Implantable Cardioverter Defibrillator 38%
9. Ventricular Tachycardia 36%
10. Laboratory 35%
11. Ertugliflozin 31%
12. Lesion 31%
13. Vitamin K Antagonist 31%
14. Thromboembolism 31%
15. Antithrombotic 31%
16. Atrial Fibrillation Ablation 31%
17. Shock (Circulatory) 27%
18. Apoplexy 19%
19. Ischemic Cardiomyopathy 17%
20. Ejection Fraction 13%
21. Lead 12%
22. Female 12%
23. Age 12%
24. Hemoglobin 11%
25. Follow up 10%
26. Cardioversion 10%
27. Pulmonary Vein Isolation 10%
28. Brain Embolism 10%
29. Incidence 10%
30. Multivariate Analysis 9%
31. Sodium Glucose Cotransporter 2 9%
32. Heart Failure 9%
33. Primary Prevention 9%
34. Heart Failure with Reduced Ejection Fraction 9%
35. Dilated Cardiomyopathy 9%
36. Disease 9%
37. Diabetes 9%
38. Placebo 9%
39. Therapeutic Procedure 8%
40. Cardiac Dysrhythmia 8%
41. End Stage Renal Disease 7%
42. Position 6%
43. Cardiovascular System 6%
44. Enalapril Maleate 5%
45. Magnetic Resonance Imaging 5%
46. Anticoagulation 5%
47. Rivaroxaban 5%
48. Dabigatran 5%
49. Apixaban 5%
50. Edoxaban 5%